SQZBiotech

Unlocking the full potential of cell therapies for patients around the world

[SQZBiotech @SQZBiotech]

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial https://t.co/zMEcXn4hbn $SQZ

[SQZBiotech @SQZBiotech]

In recognition of #WorldDiabetesDay, we’re revisiting this #HowCellsWork episode, which looks at how immune tolerance therapies could change the treatment paradigm for #Type1Diabetes & improve patient quality of life. Cc @JDRF

[SQZBiotech @SQZBiotech]

At #mRNA2022 today, @ilkeremrahozay presented on how the Cell Squeeze® Technology can be used to generate Enhanced Antigen Presenting Cells (SQZ® eAPCs) that amplify CD8+ T cell responses  @mrnaconference

[SQZBiotech @SQZBiotech]

At #SITC22, we shared preclinical data showing that SQZ® eAPCs with mRNA encoding multiple linked antigens could represent a potential model for a personalized neoantigen medicine for mutations like #KRAS: https://t.co/bnMXNOxj17 $SQZ #CellTherapy

[SQZBiotech @SQZBiotech]

SQZ Biotechnologies ($SQZ) Reports Third Quarter 2022 Financial Results and Recent Portfolio Updates: https://t.co/OBadVYolC0

[SQZBiotech @SQZBiotech]

At #SITC22, we’ll be presenting 3 posters, which highlight:
- our Cell Squeeze® platform
- linked antigen mRNA preclinical research
- our COMMANDER-001 (SQZ® eAPC) Trial in Progress
$SQZ

[Support For People With Oral, Head And Neck Cancer @spohnc_1]

We are pleased to share the Clinical Trials and Immunotherapy for Head and Neck Cancer webinar.

Presented by @SQZBiotech, SPOHNC and @hncalliance. Much thanks and appreciation to our guest speakers. https://t.co/SrO2u3IxQd

[Head and Neck Cancer Alliance @hncalliance]

We are happy to share the recording of the webinar, Clinical Trials and Immunotherapy for Head and Neck Cancer: 3 Different Perspectives (Presented by SQZ Biotechnologies, SPOHNC and Head and Neck Cancer Alliance)https://t.co/sJc0aNZbPR

[SQZBiotech @SQZBiotech]

About 70% of oropharyngeal cancers are linked to human papillomavirus (HPV). In this #HowCellsWork episode, we explore how #HPV can cause #headandneckcancer:

[Ragon Institute @ragoninstitute]

Ragon Seminar Tuesday 10/25 at noon ET: Join us for a presentation by @ArmonSharei, CEO and founder @SQZBiotech.

Sign up for our seminar email list: https://t.co/nQr4oNGfgS

[SQZBiotech @SQZBiotech]

Join us tomorrow 10/12 with @spohnc_1 & @hncalliance for a webinar on clinical trials and #immunotherapy for #headandneckcancers. Learn more and register at: https://t.co/Depj2mODgZ

[SQZBiotech @SQZBiotech]

Stephane Calmat, PhD, SQZ Director of Analytical Development, presents on "Early adoption of RMM technologies to enable novel cell therapies for patient needs" at @PDAonline Microbiology Conference Cc @MilliporeSigma

[SQZBiotech @SQZBiotech]

In his @INVIVOnow article, SQZ CEO @ArmonSharei discusses both the challenges and the promise for patients in advancing #celltherapies in oncology. Read the article: https://t.co/hnEW10HdrP

[SQZBiotech @SQZBiotech]

Join us with @spohnc_1 & @hncalliance on 10/12 for a webinar on clinical trials and #immunotherapy for #headandneckcancers. Learn more and register at: https://t.co/Depj2mO5rr

[SQZBiotech @SQZBiotech]

Preclinical data published in @FrontImmunol demonstrates that SQZ® Activating Antigen Carriers (AACs) have the potential to be an effective red blood cell-derived cancer #immunotherapy. Learn more: https://t.co/Jpn2vps7hT #celltherapy

[SQZBiotech @SQZBiotech]

We are proud to sponsor @HPVAnalCancer’s Patient Summit, a full day of expert sessions focused on #analcancer treatment, side effects, prevention, and community. Learn more & register at: https://t.co/XEgm1w57jE

[SQZBiotech @SQZBiotech]

Join SQZ CEO @ArmonSharei at #BiotechWeekBoston on 9/28 for a panel on “Beyond Rare Diseases - Overcoming the Challenges of Expanding to Larger Patient Populations with Cell and Gene Therapies” with @Atarabio & @BioCentriq https://t.co/lcxCHgFoce

[SQZBiotech @SQZBiotech]

It’s #WorldCancerResearchDay. Today and every day, we’re working to advance treatments for cancer patients. Learn more about how our clinical trials seek to put patients’ own immune systems to work to fight their cancer:
https://t.co/i9ZIIVrVSF

[SQZBiotech @SQZBiotech]

Join SQZ CEO & @MIT alum @ArmonSharei as he presents the inaugural Charles L. Cooney Lecture @MITChemE on Friday, 9/23 at 3pm: https://t.co/TiZztWEDZr Cc @MIT_alumni @MITEngineering @MITdeptofBE

[SQZBiotech @SQZBiotech]

Join SQZ CEO @ArmonSharei on 9/21 for a panel on “The Next Wave of Targeted Therapies” at the #LongwoodHealthcareLeaders Webconference. Learn more: https://t.co/wDBLLNhd75 Cc @LongwoodLeaders